Aim:. To investigate the clinical outcomes of elbows with post-traumatic stiffness treated by
Outcomes following carpal tunnel release are generally favorable. Understanding factors that contribute to inferior outcomes may allow for strategies targeted at improving results in these patients. Our purpose was to determine if patients' underlying personality traits, specifically resiliency and catastrophization, impact their post-operative outcomes following carpal tunnel release. A prospective case series was performed. Based on our power analysis, 102 patients were recruited. Patients completed written consent, the Boston Carpal Tunnel Questionnaire (BCTQ), the Pain Catastrophizing Scale (PCS) and the Brief Resiliency Scale (BRS). A single surgeon, or his resident under supervision, then performed an
The process by which pathologic scar tissue forms after TKA and restricts functional range of motion is relatively poorly understood. Arthrofibrosis may develop in patients who have normal intra-operative range of motion (ROM). However, passive flexion, extension, or both can become restricted and painful, sometimes several weeks after surgery following an early post-operative period of normal motion. The response to both nonsurgical and surgical treatment is often unsatisfactory. Arthrofibrotic scar contains dense fibrous tissue with abundant fibroblasts. Heterotopic bone is frequently found in patients with arthrofibrosis. Stiffness may result from inadequate postsurgical pain management or rehabilitation or from a biologic process that causes rapid proliferation of scar tissue. Genetic factors also may play a role, although it is difficult to predict which patients are at increased risk for arthrofibrosis after TKA. Surgical technique also can contribute; oversizing the femoral component, overstuffing the patella, or rotational malalignment can play a role. Manipulation can be helpful, particularly during the first three months after surgery. However, maintaining motion long term also requires an effective pain management and physical therapy program after manipulation. Arthroscopy may also have a role to remove scar tissue in the suprapatellar pouch and medial and lateral gutters usually between six months and one year after TKA. After one year following TKA,
Percutaneous A1 pulley release is being increasingly used as an alternative to
Patellofemoral unicompartmental joint replacement is a controversial subject with a relatively small evidence base. Of the 50,000 total knee arthroplasties performed each year in the UK, approximately 10% are performed for predominantly patellofemoral arthritis. There are several patellofemoral unicompartmental prostheses on the market with the National Joint Registry recording 745 such prostheses used in 2007. Most evidence in favour of this procedure comes from experience with the Avon prosthesis (Stryker) predominantly from designer-surgeons. The FPV patellofemoral joint replacement (Wright Medical) has been in use in Europe for several years. The instruments have recently been redesigned and the device marketed in the UK. In 2007 the FPV had 5.9% market share (n=44). We present our early experience with the FPV patellofemoral joint replacement, which to our knowledge, is the first clinical outcome series for this prosthesis. 33 consecutive FPV joint replacements in 29 patients were performed between April 2007 and September 2009 for unicompartmental patellofemoral OA. All cases were performed or directly supervised by the senior author. Results are presented with a minimum follow-up of six months. Oxford and American Knee Society scores (AKSS) were obtained on all patients preoperatively and at subsequent outpatient visits. Mean preoperative AKSS knee score was 49.7 points and postoperative scores at 6 months and 1 year were 82.5 and 86.4 respectively. Mean Oxford score preoperatively was 30.4 (37%) and at 6 months and 1 year were 21.3 (56%) and 11.2 (77%) respectively. There were no complications related to the implant. One knee required a secondary